You are viewing a preview of this job. Log in or register to view more details about this job.

FDA Bioinformatics Scientist Fellowship

*Applications will be reviewed on a rolling-basis.

A research opportunity is available with the High-Performance Integrated Virtual Environment (HIVE) Team within the Office of Biostatistics and Epidemiology (OBE), Center for Biologics Evaluation and Research (CBER), at the Food and Drug Administration (FDA) in Silver Spring, MD. 
The HIVE Team is seeking a bioinformatics and data analyst for fellowships in Master's and/or Ph.D. training programs. The participant will train under a team of multi-disciplinary scientists and perform bioinformatics data analysis in the rapidly changing environment of next-generation sequencing and other omics technologies. As a result of this training the participant will acquire new skills in NGS quality assessment analysis, genome and transcriptome analysis and improve their software development and communication skills.

Under the guidance of a mentor, responsibilities will include:
  • Assisting researchers’ access, analyze, store and transmit NGS data and information, and collaborating effectively
  • Identify, import and evaluate genomic datasets and pipelines
  • Develop novel bioinformatic pipelines, scientific algorithms and adopt existing tools
  • Communication of results and interpretation to a diverse audience, including senior FDA scientists, collaborators, and internal stakeholders

Anticipated Appointment Start Date: June 2022; start date is flexible

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.

FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
  • Non-employee nature of the ORISE appointment;
  • Prohibition on ORISE Fellows performing inherently governmental functions;
  • Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship;
  • The fact that research materials and laboratory notebooks are the property of the FDA;
  • ORISE fellow’s obligation to protect and not to further disclose or use non-public information.